Cosmos Pharmaceutical Corp
TSE:3349
Cosmos Pharmaceutical Corp
Operating Income
Cosmos Pharmaceutical Corp
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Cosmos Pharmaceutical Corp
TSE:3349
|
Operating Income
¥30.6B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
6%
|
|
Sundrug Co Ltd
TSE:9989
|
Operating Income
¥41.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Tsuruha Holdings Inc
TSE:3391
|
Operating Income
¥48.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
3%
|
CAGR 10-Years
8%
|
|
Welcia Holdings Co Ltd
TSE:3141
|
Operating Income
¥45.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
13%
|
|
S
|
Sugi Holdings Co Ltd
TSE:7649
|
Operating Income
¥36.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
MatsukiyoCocokara & Co
TSE:3088
|
Operating Income
¥72.7B
|
CAGR 3-Years
29%
|
CAGR 5-Years
15%
|
CAGR 10-Years
13%
|
See Also
What is Cosmos Pharmaceutical Corp's Operating Income?
Operating Income
30.6B
JPY
Based on the financial report for Nov 30, 2023, Cosmos Pharmaceutical Corp's Operating Income amounts to 30.6B JPY.
What is Cosmos Pharmaceutical Corp's Operating Income growth rate?
Operating Income CAGR 10Y
6%
Over the last year, the Operating Income growth was 1%. The average annual Operating Income growth rates for Cosmos Pharmaceutical Corp have been -5% over the past three years , 4% over the past five years , and 6% over the past ten years .